Descriptor English: | Mechanistic Target of Rapamycin Complex 2 | ||||||
Descriptor Spanish: |
Diana Mecanicista del Complejo 2 de la Rapamicina
| ||||||
Descriptor Portuguese: | Alvo Mecanístico do Complexo 2 de Rapamicina | ||||||
Descriptor French: | Complexe-2 cible mécanistique de la rapamycine | ||||||
Entry term(s): |
Complex 2, TOR MTORC-2 TOR Complex 2 TORC2 Target of Rapamycin Complex 2 mTORC2 |
||||||
Tree number(s): |
D05.500.356 D08.811.913.696.620.682.700.931.750 D12.776.476.563.931.750 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000076225 | ||||||
Scope note: | A multiprotein complex consisting of mTOR KINASE; MLST8 PROTEIN; rapamycin-insensitive companion of mTOR protein (RICTOR PROTEIN); and PRR5 (proline-rich protein 5). Like mTORC1, it also regulates cell growth and proliferation in response to growth factors but may not be as sensitive to nutrient availability and is insensitive to SIROLIMUS. In contrast to mTORC1, it can regulate the ACTIN CYTOSKELETON through RHO GTPASES to promote the formation of STRESS FIBERS. The mTORC2 complex also plays a critical role in AKT1 PROTEIN KINASE phosphorylation and activation. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Registry Number: | EC 2.7.11.1 | ||||||
Public MeSH Note: | 2018; see TOR COMPLEX 2 2013-2017; MECHANISTIC TARGET OF RAPAMYCIN 2 COMPLEX was indexed under MULTIPROTEIN COMPLEXES and TOR SERINE-THREONINE KINASES 2013-2017 |
||||||
History Note: | 2018 (2013) |
||||||
DeCS ID: | 56985 | ||||||
Unique ID: | D000076225 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2018/01/01 | ||||||
Date of Entry: | 2017/07/11 | ||||||
Revision Date: | 2018/10/10 |
-
-
CHEMICALS AND DRUGS
Macromolecular Substances [D05]Macromolecular Substances -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Mechanistic Target of Rapamycin Complex 2
- Preferred
Concept UI |
M0579319 |
Scope note | A multiprotein complex consisting of mTOR KINASE; MLST8 PROTEIN; rapamycin-insensitive companion of mTOR protein (RICTOR PROTEIN); and PRR5 (proline-rich protein 5). Like mTORC1, it also regulates cell growth and proliferation in response to growth factors but may not be as sensitive to nutrient availability and is insensitive to SIROLIMUS. In contrast to mTORC1, it can regulate the ACTIN CYTOSKELETON through RHO GTPASES to promote the formation of STRESS FIBERS. The mTORC2 complex also plays a critical role in AKT1 PROTEIN KINASE phosphorylation and activation. |
Preferred term | Mechanistic Target of Rapamycin Complex 2 |
Entry term(s) |
Complex 2, TOR MTORC-2 TOR Complex 2 TORC2 Target of Rapamycin Complex 2 mTORC2 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey